{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:29:13Z","timestamp":1789878553497,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd010469","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T00:00:00Z","timestamp":1455235200000}}],"reference-count":79,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010469.pub2","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T01:42:20Z","timestamp":1455241340000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Corticosteroid implants for chronic non-infectious uveitis"],"prefix":"10.1002","volume":"2016","author":[{"given":"Christopher J","family":"Brady","sequence":"first","affiliation":[{"name":"Johns Hopkins University School of Medicine; Wilmer Eye Institute; Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea C","family":"Villanti","sequence":"additional","affiliation":[{"name":"Johns Hopkins Bloomberg School of Public Health; Department of Health, Behavior and Society; Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua Andrew","family":"Law","sequence":"additional","affiliation":[{"name":"Johns Hopkins Bloomberg School of Public Health; Department of Epidemiology; 615 N. Wolfe Street Baltimore Maryland USA 21205"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Rahimy","sequence":"additional","affiliation":[{"name":"Thomas Jefferson University; MidAtlantic Retina, The Retina Service of Wills Eye Hospital; Philadelphia Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Reddy","sequence":"additional","affiliation":[{"name":"Associated Retinal Consultants; Phoenix Arizona USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela C","family":"Sieving","sequence":"additional","affiliation":[{"name":"National Institutes of Health Library; 10 Center Drive Room 1L09G MSC 1150 Bethesda Maryland USA 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunir J","family":"Garg","sequence":"additional","affiliation":[{"name":"Thomas Jefferson University; MidAtlantic Retina, The Retina Service of Wills Eye Hospital; Philadelphia Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny","family":"Tang","sequence":"additional","affiliation":[{"name":"University Hospitals Eye Institute\/Case Western Reserve University; University Hospitals Eye Institute; 11100 Euclid Avenue, Lakeside 4107 Cleveland Ohio USA 44106"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,2,12]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD010469.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1167\/iovs.11-8259","article-title":"Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial","volume":"53","author":"Frick","year":"2012","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"8","key":"10.1002\/14651858.CD010469.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.ophtha.2013.01.025","article-title":"Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial","volume":"120","author":"Friedman","year":"2013","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD010469.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1177\/1740774511423682","article-title":"Challenges in the design and implementation of the Multicenter Uveitis Steroid Treatment (MUST) Trial - lessons for comparative effectiveness trials","volume":"8","author":"Holbrook","year":"2011","journal-title":"Clinical Trials"},{"issue":"10","key":"10.1002\/14651858.CD010469.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.ophtha.2011.07.027","article-title":"Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial","volume":"118","author":"Kempen","year":"2011","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD010469.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ajo.2009.11.019","article-title":"The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics","volume":"149","author":"Kempen","year":"2010","journal-title":"American Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD010469.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ophtha.2011.12.001","article-title":"Erratum: Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: The Multicenter Uveitis Steroid Treatment Trial (Ophthalmology (2011) 118 (1916-26))","volume":"119","author":"Kempen","year":"2012","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD010469.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.ophtha.2015.06.043","article-title":"Quality of life and risks associated with systemic anti-inflammatory therapy versus fluocinolone acetonide intraocular implant for intermediate uveitis, posterior uveitis, or panuveitis: fifty-four-month results of the Multicenter Uveitis Steroid Treatment Trial and Follow-up Study","volume":"122","author":"Multicenter Uveitis Steroid Treatment Trial Follow-up Study Research Group","year":"2015","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD010469.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.ophtha.2014.04.022","article-title":"Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis","volume":"121","author":"Sugar","year":"2014","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD010469.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.ophtha.2015.07.036","article-title":"Outcome of treatment of uveitic macular edema: the Multicenter Uveitis Steroid Treatment Trial 2-year results","volume":"122","author":"Tomkins-Netzer","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD010469.pub2-BIB0010|cit10","doi-asserted-by":"crossref","unstructured":"Pavesio C Zierhut M Bairi K Comstock TL Usner DW Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis Ophthalmology 2010 567 75","DOI":"10.1016\/j.ophtha.2009.11.027"},{"key":"10.1002\/14651858.CD010469.pub2-BIB0011|cit11","unstructured":"Pavesio CE Bairi K Evaluation of an intravitreal fluocinolone acetonide implant vs. standard systemic therapy in noninfectious posterior uveitis American Academy of Ophthalmology 2006 194"},{"issue":"3","key":"10.1002\/14651858.CD010469.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00004397-200404430-00006","article-title":"Sustained-release drug implants for the treatment of intraocular disease","volume":"44","author":"Acharya","year":"2004","journal-title":"International Ophthalmology Clinics"},{"issue":"16","key":"10.1002\/14651858.CD010469.pub2-BIB0013|cit13","first-page":"4","article-title":"Good results from eye implant study","author":"Anonymous","year":"1995","journal-title":"Treatment Review"},{"issue":"5","key":"10.1002\/14651858.CD010469.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ajo.2010.03.001","article-title":"Proof of concept for combined insertion of fluocinolone acetonide and glaucoma drainage implants for eyes with uveitis and glaucoma","volume":"149","author":"Ansari","year":"2010","journal-title":"American Journal of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD010469.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/jop.2012.0180","article-title":"A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis","volume":"29","author":"Arcinue","year":"2013","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD010469.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/ICU.0b013e32831d7f3a","article-title":"Prevalence and management of elevated intraocular pressure after placement of an intravitreal sustained-release steroid implant","volume":"20","author":"Bollinger","year":"2009","journal-title":"Current Opinion in Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD010469.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/archopht.126.9.1191","article-title":"Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results","volume":"126","author":"Callanan","year":"2008","journal-title":"Archives of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD010469.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ophtha.2012.09.014","article-title":"Aqueous levels of fluocinolone acetonide after administration of fluocinolone acetonide inserts or fluocinolone acetonide implants","volume":"120","author":"Campochiaro","year":"2013","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD010469.pub2-BIB0019|cit19","first-page":"671","article-title":"New drugs in the treatment of noninfectious uveitis","volume":"81","author":"Cano-Parra","year":"2006","journal-title":"Archivos de la Sociedad Espanola de Oftalmologia"},{"key":"10.1002\/14651858.CD010469.pub2-BIB0020|cit20","unstructured":"CTRI\/2014\/12\/004726 To assess the safety & efficacy of fluocinolone acetonide intravitreal (FAI) insert in patients with chronic, non-infectious uveitis affecting the posterior segment of the eye www.ctri.nic.in\/Clinicaltrials\/pmaindet2.php?trialid=8285"},{"key":"10.1002\/14651858.CD010469.pub2-BIB0021|cit21","unstructured":"CTRI\/2014\/07\/005337 A research to study the effect of fluocinolone Aaetonide intravitreal (FAI) insert in patients with inflammation of middle layer of the eye http:\/\/www.ctri.nic.in\/Clinicaltrials\/pmaindet2.php?trialid=9684"},{"issue":"3","key":"10.1002\/14651858.CD010469.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/IEB.0b013e31809fdfb9","article-title":"Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema: Commentary","volume":"8","author":"Eng","year":"2007","journal-title":"Evidence-Based Ophthalmology"},{"key":"10.1002\/14651858.CD010469.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/0-306-48382-3_114","article-title":"Efficacy of corticosteroids and cyclosporin in the treatment of retinal vasculitis in patients with Behcet's disease","volume":"528","author":"Ermakova","year":"2003","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"6","key":"10.1002\/14651858.CD010469.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/archopht.125.6.836","article-title":"Vitreous band formation and the sustained-release, intravitreal fluocinolone (Retisert) implant","volume":"125","author":"Galor","year":"2007","journal-title":"Archives of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD010469.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/01.ieb.0000212045.32643.17","article-title":"Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: Thirty-four-week results of a multicenter randomized clinical study","volume":"7","author":"Garg","year":"2006","journal-title":"Evidence-Based Ophthalmology"},{"key":"10.1002\/14651858.CD010469.pub2-BIB0026|cit26","doi-asserted-by":"crossref","unstructured":"Goldstein DA Godfrey DG Hall A Callanan DG Jaffe GJ Pearson PA Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants Archives of Ophthalmology 2007 1478 85","DOI":"10.1001\/archopht.125.11.ecs70063"},{"issue":"4","key":"10.1002\/14651858.CD010469.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/IEB.0b013e3181b95d92","article-title":"Treatment of posterior uveitis with a fluocinolone acetonide implant","volume":"10","author":"Ibrahim","year":"2009","journal-title":"Evidence-Based Ophthalmology"},{"key":"10.1002\/14651858.CD010469.pub2-BIB0028|cit28","doi-asserted-by":"crossref","unstructured":"Jaffe GJ Ben-Nun J Guo H Dunn JP Ashton P Fluocinolone acetonide sustained drug delivery device to treat severe uveitis Ophthalmology 2000 2024 33","DOI":"10.1016\/S0161-6420(00)00466-8"},{"key":"10.1002\/14651858.CD010469.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00006982-200004000-00015","article-title":"Dexamethasone sustained drug delivery implant for the treatment of severe uveitis","volume":"20","author":"Jaffe","year":"2000","journal-title":"Retina"},{"issue":"13","key":"10.1002\/14651858.CD010469.pub2-BIB0030|cit30","first-page":"ARVO E-abstract","article-title":"Fluocinolone acetonide intravitreal implant to treat posterior uveitis: 2-year results of a multi-center clinical trial","volume":"46","author":"Jaffe","year":"2005","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1002\/14651858.CD010469.pub2-BIB0031|cit31","doi-asserted-by":"crossref","unstructured":"Jaffe GJ McCallum RM Branchaud B Skalak C Butuner Z Ashton P Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis Ophthalmology 2005 1192 8","DOI":"10.1016\/j.ophtha.2005.03.013"},{"key":"10.1002\/14651858.CD010469.pub2-BIB0032|cit32","doi-asserted-by":"crossref","unstructured":"Jaffe GJ Martin D Callanan D Pearson PA Levy B Comstock T Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study Ophthalmology 2006 1020 7","DOI":"10.1016\/j.ophtha.2006.02.021"},{"issue":"13","key":"10.1002\/14651858.CD010469.pub2-BIB0033|cit33","first-page":"ARVO E-abstract","article-title":"Fluocinolone acetonide intravitreal implant to treat posterior segment uveitis: 3-year results of a multi-center clinical trial","volume":"47","author":"Jaffe","year":"2006","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"1","key":"10.1002\/14651858.CD010469.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/IIO.0b013e318200e01b","article-title":"Diagnosis and management of noninfectious pediatric uveitis","volume":"51","author":"Kim","year":"2011","journal-title":"International Ophthalmology Clinics"},{"key":"10.1002\/14651858.CD010469.pub2-BIB0035|cit35","doi-asserted-by":"crossref","unstructured":"Kuppermann BD Blumenkranz MS Haller JA Williams GA Weinberg DV Chou C Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema Archives of Ophthalmology 2007 309 17","DOI":"10.1001\/archopht.125.3.309"},{"issue":"7","key":"10.1002\/14651858.CD010469.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.1167\/iovs.12-10981","article-title":"Vision-related functioning outcomes of dexamethasone intravitreal implant in noninfectious intermediate or posterior uveitis","volume":"54","author":"Lightman","year":"2013","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"5","key":"10.1002\/14651858.CD010469.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","article-title":"Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis","volume":"129","author":"Lowder","year":"2011","journal-title":"Archives of Ophthalmology"},{"issue":"13","key":"10.1002\/14651858.CD010469.pub2-BIB0038|cit38","first-page":"ARVO E-Abstract","article-title":"Cystoid macular edema in non-infectious uveitis treated with fluocinolone acetonide intravitreal implant: 3-year results of a multi-center clinical trial","volume":"48","author":"Mercante","year":"2007","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1002\/14651858.CD010469.pub2-BIB0039|cit39","doi-asserted-by":"crossref","unstructured":"Muller B Orlic N Pleyer U Intravitreal fluocinolone-implant (Retisert) in posterior non-infectious uveitis - intermediate results after 34 weeks Klinische Monatsblatter fur Augenheilkunde 2004 S8","DOI":"10.1055\/s-2004-837150"},{"issue":"6","key":"10.1002\/14651858.CD010469.pub2-BIB0040|cit40","first-page":"719","article-title":"Corticosteroid efficacy in postoperative uveitis","volume":"5","author":"Mustakallio","year":"1973","journal-title":"Annals of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD010469.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/2013.jamaophthalmol.102","article-title":"Normative comparison of patient-reported outcomes in patients with noninfectious uveitis","volume":"131","author":"Naik","year":"2013","journal-title":"JAMA Ophthalmology"},{"key":"10.1002\/14651858.CD010469.pub2-BIB0042|cit42","unstructured":"NCT01694186 Safety and efficacy of an injectable fluocinolone acetonide intravitreal insert clinicaltrials.gov\/show\/NCT01694186"},{"key":"10.1002\/14651858.CD010469.pub2-BIB0043|cit43","unstructured":"NCT02309385 Safety and efficacy study of DSP-visulex for the treatment of anterior uveitis clinicaltrials.gov\/show\/NCT02309385"},{"key":"10.1002\/14651858.CD010469.pub2-BIB0044|cit44","unstructured":"NCT02482129 Proof of concept study to evaluate safety and efficacy of LME636 in the treatment of acute anterior uveitis clinicaltrials.gov\/show\/NCT02482129"},{"key":"10.1002\/14651858.CD010469.pub2-BIB0045|cit45","unstructured":"NCT02517619 Safety and efficacy of iontophoretic dexamethasone phosphate ophthalmic solution in non-infectious anterior uveitis (EGP-437-006) clinicaltrials.gov\/show\/NCT02517619"},{"issue":"3","key":"10.1002\/14651858.CD010469.pub2-BIB0046|cit46","first-page":"10","article-title":"The eyes have it, too","volume":"7","author":"Neger","year":"1996","journal-title":"Positively Aware: the Monthly Journal of the Test Positive Aware Network"},{"issue":"4","key":"10.1002\/14651858.CD010469.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1542-0124(12)70180-5","article-title":"Clinical indications for ophthalmic corticosteroids","volume":"6","author":"Novack","year":"2008","journal-title":"Ocular Surface"},{"issue":"6","key":"10.1002\/14651858.CD010469.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3109\/09273948.2013.822087","article-title":"Intraoperative dexamethasone implant in uveitis patients with cataract undergoing phacoemulsification","volume":"21","author":"Ram","year":"2013","journal-title":"Ocular Immunology and Inflammation"},{"key":"10.1002\/14651858.CD010469.pub2-BIB0049|cit49","unstructured":"Sangwan V S Paul H A Usner D W Safety and efficacy of an intravitreal fluocinolone acetonide implant in subjects with noninfectious uveitis American Academy of Ophthalmology 2007 199"},{"issue":"12","key":"10.1002\/14651858.CD010469.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1001\/archophthalmol.2011.355","article-title":"A report of high intraocular pressure with the dexamethasone intravitreal implant","volume":"129","author":"Saraiya","year":"2011","journal-title":"Archives of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD010469.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2147\/OPTH.S24397","article-title":"Post-cataract outcomes in patients with noninfectious posterior uveitis treated with the fluocinolone acetonide intravitreal implant","volume":"6","author":"Sheppard Jr","year":"2012","journal-title":"Clinical Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD010469.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/j.ophtha.2012.07.025","article-title":"Dexamethasone implant in pediatric uveitis","volume":"119","author":"Taylor","year":"2012","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD010469.pub2-BIB0053|cit53","first-page":"115","article-title":"Uveitis treated with fluocinolone acetonide implants","volume":"127","author":"Viola","year":"2009","journal-title":"Archives of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD010469.pub2-BIB0054|cit54","first-page":"205","article-title":"Comparison of Chinese traditional therapy combined with Western medicine and Western medicine alone in the treatment of uveitis","volume":"7","author":"Wen","year":"1991","journal-title":"Eye Science"},{"key":"10.1002\/14651858.CD010469.pub2-BIB0055|cit55","unstructured":"Williams G A Kuppermann B D Blumenkranz M S Haller J A Whitcup S M Weinberg D V Treatment of inflammatory macular edema with a dexamethasone posterior-segment drug delivery system American Academy of Ophthalmology 2004 87"},{"key":"10.1002\/14651858.CD010469.pub2-BIB0056|cit56","doi-asserted-by":"crossref","unstructured":"Williams GA Haller JA Kuppermann BD Blumenkranz MS Weinberg DV Chou C Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome American Journal of Ophthalmology 2009 1048 54","DOI":"10.1016\/j.ajo.2008.12.033"},{"issue":"9","key":"10.1002\/14651858.CD010469.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/archopht.126.9.1287","article-title":"Fluocinolone acetonide for the treatment of uveitis: weighing the balance between local and systemic immunosuppression","volume":"126","author":"Yeh","year":"2008","journal-title":"Archives of Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD010469.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.ophtha.2011.02.042","article-title":"Intraocular pressure outcome of patients with fluocinolone acetonide intravitreal implant for noninfectious uveitis","volume":"118","author":"Bollinger","year":"2011","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD010469.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/archopht.126.9.1191","article-title":"Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results","volume":"126","author":"Callanan","year":"2008","journal-title":"Archives of Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD010469.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.ophtha.2009.11.024","article-title":"Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert","volume":"117","author":"Campochiaro","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD010469.pub2-BIB0061|cit61","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"4","key":"10.1002\/14651858.CD010469.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000078612","article-title":"Uveitis: a potentially blinding disease","volume":"218","author":"Durrani","year":"2004","journal-title":"Ophthalmologica"},{"issue":"2","key":"10.1002\/14651858.CD010469.pub2-BIB0063|cit63","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"4","author":"Glanville","year":"2006","journal-title":"Journal of the Medical Library Association"},{"issue":"11","key":"10.1002\/14651858.CD010469.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/archopht.125.11.ecs70063","article-title":"Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants","volume":"125","author":"Goldstein","year":"2007","journal-title":"Archives of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD010469.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ophtha.2003.06.014","article-title":"Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study","volume":"111","author":"Gritz","year":"2004","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD010469.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ophtha.2010.03.032","article-title":"Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion","volume":"117","author":"Haller","year":"2010","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD010469.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00004397-200004000-00015","article-title":"New and emerging treatments for patients with uveitis","volume":"40","author":"Haupert","year":"2000","journal-title":"International Ophthalmology Clinics"},{"key":"10.1002\/14651858.CD010469.pub2-BIB0068|cit68","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from: www.cochrane-handbook.org"},{"issue":"5","key":"10.1002\/14651858.CD010469.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/00006982-200410000-00002","article-title":"Risks of intravitreous injection: a comprehensive review","volume":"24","author":"Jager","year":"2004","journal-title":"Retina"},{"issue":"10","key":"10.1002\/14651858.CD010469.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.ophtha.2011.07.027","article-title":"Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the Multicenter Uveitis Steroid Treatment trial","volume":"118","author":"Kempen","year":"2011","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD010469.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","article-title":"Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis","volume":"129","author":"Lowder","year":"2011","journal-title":"Archives of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD010469.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1345\/aph.1H540","article-title":"Retisert: is the new advance in treatment of uveitis a good one?","volume":"41","author":"Mohammad","year":"2007","journal-title":"Annals of Pharmacotherapy"},{"issue":"5-6","key":"10.1002\/14651858.CD010469.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00163549","article-title":"The natural history of uveitis","volume":"14","author":"Nussenblatt","year":"1990","journal-title":"International Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD010469.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ophtha.2009.11.027","article-title":"Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis","volume":"117","author":"Pavesio","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD010469.pub2-BIB0075|cit75","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD010469.pub2-BIB0076|cit76","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from: www.cochrane-handbook.org"},{"issue":"9","key":"10.1002\/14651858.CD010469.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/bjo.80.9.844","article-title":"The possible impact of uveitis in blindness: a literature survey","volume":"80","author":"Suttorp-Schulten","year":"1996","journal-title":"British Journal of Ophthalmology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010469.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000318021","article-title":"New developments in corticosteroid therapy for uveitis","volume":"224","author":"Taylor","year":"2010","journal-title":"Ophthalmologica"},{"issue":"6","key":"10.1002\/14651858.CD010469.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ajo.2008.12.033","article-title":"Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome","volume":"147","author":"Williams","year":"2009","journal-title":"American Journal of Ophthalmology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd010469.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD010469.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T12:52:37Z","timestamp":1642423957000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010469.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,12]]},"references-count":79,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010469.pub2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726141395.793529315","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,12]]}}}